FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.

MLA

Rezaei, Narges, et al. “FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.” Turkish Journal of Hematology, vol. 34, no. 4, Oct. 2017, pp. 300–06. EBSCOhost, https://doi.org/10.4274/tjh.2016.0489.

APA

Rezaei, N., Arandi, N., Valibeigi, B., Haghpanah, S., Khansalar, M., & Ramzi, M. (2017). FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics. Turkish Journal of Hematology, 34(4), 300–306. https://doi.org/10.4274/tjh.2016.0489

Chicago

Rezaei, Narges, Nargess Arandi, Behnaz Valibeigi, Sezaneh Haghpanah, Mehdi Khansalar, and Mani Ramzi. 2017. “FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.” Turkish Journal of Hematology 34 (4): 300–306. doi:10.4274/tjh.2016.0489.